How much is Vella Bioscience worth in 2026?

Vella Bioscience has a current valuation of N/A based on their Accelerator/Incubator round and secondary market data.

How much funding has Vella Bioscience raised?

Vella Bioscience has raised $12.5M in total funding across 1 funding rounds.

Vella Bioscience

Personal ProductsWebsite

Vella Bioscience valuation and funding history | Last updated: February 26, 2025 | 1 funding rounds

Current Valuation

N/A

As of February 26, 2025

Total Funding Raised

$12.5M

Across 1 round

Last Round

Accelerator/Incubator

Amount undisclosed

Last Funding

Feb 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 26, 2025	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Vella Bioscience is currently valued at N/A as of February 26, 2025. The company has raised a total of $12.5M in funding across 1 funding round.

Track Vella Bioscience Valuation Updates

Get notified when Vella Bioscience raises new funding or valuation changes

Explore More Data

Detailed analysis for Vella Bioscience

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Vella Bioscience's valuation history, funding rounds, and growth metrics.

No credit card required

What is Vella Bioscience Worth in 2026?

Vella Bioscience is a leading private company in the Personal Products sector. Track Vella Bioscience's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Vella Bioscience Valuation is Determined

Private company valuations like Vella Bioscience's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.